Vantage Consulting Group Inc has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $7.71 Million distributed in 4 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Babcock & Wilcox Enterprises, Inc. with a value of $4.95M, Adc Therapeutics Sa with a value of $2.68M, Fibrogen Inc with a value of $78K, and Cibus Inc with a value of $0.

Examining the 13F form we can see an decrease of $53.5M in the current position value, from $61.2M to 7.71M.

Vantage Consulting Group Inc is based out at Virginia Beach, VA

Below you can find more details about Vantage Consulting Group Inc portfolio as well as his latest detailed transactions.

Portfolio value $7.71 Million
Industrials: $4.95 Million
Healthcare: $2.76 Million

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 4
  • Current Value $7.71 Million
  • Prior Value $61.2 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Vantage Consulting Group Inc Portfolio

Follow Vantage Consulting Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vantage Consulting Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vantage Consulting Group Inc with notifications on news.